[Biomarkers in endocrinology].
d'Herbomez M, Bauters C, Cortet-Rudelli C, Dewailly D, Docao C, Wémeau JL.
Presse Med. 2014 Jan;43(1):40-56. doi: 10.1016/j.lpm.2013.11.003. Epub 2013 Dec 15.
Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K, Khan S, Taghizadehasl M, Palazzo F, Frilling A, Todd JF, Al-Nahhas A.
Hell J Nucl Med. 2015 Jan-Apr;18(1):19-24. doi: 10.1967/s002449910163. Epub 2015 Feb 13.
Thyroid nodules: alpha guide to assessment, treatment and follow-up.
Paschou SA, Vryonidou A, Goulis DG.
Maturitas. 2017 Feb;96:1-9. doi: 10.1016/j.maturitas.2016.11.002. Epub 2016 Nov 9.
Medullary thyroid carcinoma and calcitonin.
Emmertsen K.
Dan Med Bull. 1985 Mar;32(1):1-28.
Calcitonin: physiology or fantasy?
Davey RA, Findlay DM.
J Bone Miner Res. 2013 May;28(5):973-9. doi: 10.1002/jbmr.1869.
Calcitonin. A review of experimental and clinical investigations.
Foster GV.
Postgrad Med J. 1968 May;44(511):411-22. doi: 10.1136/pgmj.44.511.411.
Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M, Skrabanek P, Moriarty M, McPartlin J, Powell D.
Horm Metab Res. 1982 Apr;14(4):213-5. doi: 10.1055/s-2007-1018972.
Long-term excess of endogenous calcitonin in patients with medullary thyroid carcinoma does not affect bone mineral density.
Wüster C, Raue F, Meyer C, Bergmann M, Ziegler R.
J Endocrinol. 1992 Jul;134(1):141-7. doi: 10.1677/joe.0.1340141.
Differentiation between thyroidal and ectopic calcitonin secretion in patients with coincidental thyroid nodules and pancreatic tumors - a report of two cases.
Schneider R, Heverhagen AE, Moll R, Bartsch DK, Schlosser K.
Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):520-3. doi: 10.1055/s-0029-1231083. Epub 2009 Aug 18.
Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F, Frank-Raue K.
Recent Results Cancer Res. 2015;204:207-25. doi: 10.1007/978-3-319-22542-5_10.
